Christopher A. Marlett, Director at Cue Biopharma, Inc. (CUE), sold 56,294 shares at $16.82 ($975K) on 2019-12-23, disclosed to the SEC on 2019-12-27.
Open-market sale of $975k CUE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.82 | 17,000 | $286K | 29.3% |
| 2 | $17.53 | 19,647 | $344K | 35.3% |
| 3 | $17.53 | 19,647 | $344K | 35.3% |
| Total | $17.32 avg | 56,294 | $975K | 100% |
| Filing → |
| MDBH | BUY | 2025-10-07 | $14K | — | Filing → |
| MDBH | BUY | 2025-08-29 | $11K | — | Filing → |
| MDBH | BUY | 2025-08-27 | $13K | — | Filing → |